Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.730
0.00 (0.00%)
At close: May 23, 2025, 4:00 PM
2.645
-0.085 (-3.11%)
After-hours: May 23, 2025, 4:26 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $104.21 million as of May 23, 2025. Its market cap has decreased by -41.53% in one year.
Market Cap
104.21M
Enterprise Value
70.77M
1-Year Change
-41.53%
Ranking
Category
Stock Price
$2.73
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $197.44M to $104.21M, a decrease of -47.22%. That is a compound annual growth rate of -12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2025 | 104.59M | -31.21% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.06B |
| Johnson & Johnson | 367.19B |
| AbbVie | 322.44B |
| Novo Nordisk | 299.78B |
| UnitedHealth Group | 269.12B |
| Abbott Laboratories | 228.79B |
| Novartis AG | 219.95B |
| AstraZeneca | 215.99B |